Trials / Enrolling By Invitation
Enrolling By InvitationNCT07154238
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,546 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect information for scientific research and to better understand the experiences of participants managing their weight. The study aims to collect valid responses through online interviews from participants. This study is a survey-based study without collection of laboratory data. Duration of the study will be about 14 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2025-09-26
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2025-09-04
- Last updated
- 2025-11-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07154238. Inclusion in this directory is not an endorsement.